Category Investing in China

Investing In China: Setting Up A Representative Office

Foreign investment in China started with a trickle in the early 1980s and has increased to the extent that China is now siphoning off a significant percentage of the world’s available foreign investment funding. With China’s accession to the WTO and the continuing vitality of its economy, this trend seems likely to continue for the foreseeable future.

Nevertheless, China remains an unfamiliar and challenging place to do business for many small and medium sized enterprises (SMEs). A popular way for an SME to get its feet wet in the China market without risking a lot of capital is through the establishment of a Representative Office (RO). The author touched on this topic briefly in the article “Investing in China: Establishing a Business Presence”. This article aims to delve into this topic in more detail.

Before going into the “how” of establishing an RO in China, perhaps it would be best to ask “why?”. Most companies that establish ROs in China do so because they are much easier to establish than direct investment vehicles such as joint ventures and wholly foreign owned enterprises, and generally require only about a tenth of the capital outlay. ROs are also permitted to operate in the shrinking list of industry sectors that are forbidden to direct investment vehicles.

The downside is that there are some very limiting restrictions on the type of activities that an RO may engage in. For example, an RO may not:

1. Conduct direct business activities: An RO’s activities must be confined to product promotion, market research, liaison, and the like, and it may neither charge fees for its services nor engage in profitable activities such as direct sales or manufacturing (although they are subject to taxation under certain circumstances).

2. Directly invoice clients or sign contracts: These activities must be handled by the parent company.

3. Directly hire employees: It must utilize an authorized human resources agency that will refer suitable candidates to the RO in exchange for a certain percentage of employee salaries. Some ROs make an end run around this system by directly recruiting and negotiating with employment candidates and sending their names to the authorized human resources agency so that it can then ‘refer’ these candidates back to the RO. While this practice doesn’t seem to have caused many problems with the Chinese authorities so far, the formalities of referral and salary deduction must be complied with.

In light of these restrictions, why bother establishing an RO at all?

1. A company might want to conduct market research in order to decide whether or not to make a future investment in China.

2. A company might wish to establish an RO in a business sector in which foreign investment is currently forbidden in anticipation of future liberalization of Chinese foreign investment law in line with its WTO commitments. In the meantime it can establish a presence, make local connections, and learn about the market.

3. A company might already be doing a modest amount of business with China from its home country but lack the market penetration or resources to justify a direct investment. Once the company attains greater market share it can always upgrade to a joint venture or wholly foreign owned enterprise.

4. Sectors of certain industries such as insurance and finance require foreign investors to operate an RO for at least two years before making a direct investment.

5. A company might want to use an RO to hire local employees to help them find Chinese suppliers.

6. A company might establish an RO with the aim of exceeding its legal restrictions, and thereby establish the functional equivalent of a joint venture or wholly foreign owned enterprise while avoiding much of the expense and inconvenience. This approach is not recommended, since it is likely to lead to trouble with the authorities.

By: David Carnes

China to invest forex across global markets

CHINA Investment Corp Ltd, the state investment company set up to gain better returns on China’s huge foreign exchange reserves, will invest in all markets worldwide except those that make settlement in the yuan, Chairman Lou Jiwei said yesterday.

Lou, a delegate to the ongoing 17th National Congress of the Communist Party of China in Beijing, said the company will operate in “a completely commercial way.”

“Some media reports have said China has political considerations behind the company, but I think that is an unnecessary worry,” he said.

The company, inaugurated late last month, has a board of directors and a supervisory committee that ensures its commercial operation, Lou said.

It is now working on corporate regulations and building its team.

The company will communicate with international financial institutions, multinational organizations and supervisory institutions in foreign countries, he said.

The company’s US$200 billion in registered capital comes from China’s foreign-exchange reserves. It is being assembled through the issuance of 1.55 trillion yuan (US$206 billion) in special treasury bonds by the Ministry of Finance.

China’s foreign exchange reserves reached US$1.43 trillion at the end of last month, up 45.1 percent from the same period last year, according to the People’s Bank of China.

In May, the new company, still in its preparation phase, made its first investment in US$3 million worth of nonvoting shares in Blackstone Group, a private equity firm based in the United States.

Also yesterday, Minister of Finance Xie Xuren said China will continue its “prudent” fiscal policy for the foreseeable future and keep the size of deficits and treasury bonds at “sound” levels.

Xie, who is also a delegate to the Party Congress, said the government will coordinate fiscal and monetary policies in a drive to strengthen and improve macroeconomic management.
Using a “scientific outlook on development,” Xie said the Ministry of Finance will implement policy incentives to encourage innovative companies and increase state investment in research and development in key national labs.

The financial and taxation branches of the government must build institutions that support a resources-efficient and environmentally friendly economy, Xie said.

ING eyes tieup with China Post

ING Group eyes to work with China Post and is also seeking more merger and acquisition opportunities in China, its Asia Pacific head said over the weekend.

Hans van der Noordaa, chairman of ING’s insurance & investment management Asia/Pacific, said on Saturday in Shanghai, that he has a “dream” to team up with China Post to leverage the postal body’s vast distribution network in China.

Senior officials from China Post have already visited ING’s headquarters in Amsterdam, Noordaa said, adding that it is still too early to talk of a possible future alliance. But he has a big ambition for the tieup to boost the world’s 13th biggest financial player’s growth in the fastest growing major economy.

He played down challenges that some of China Post’s clients can’t afford ING’s products and said simple and low-price products can be developed instead. He also said that ING has expertise in tying up with a postal agency as it has already done so with the postal body in Japan.

The second biggest life insurer in Asia Pacific is also open to more M&A activities in China’s assets management sector, Noordaa said.

“We have a big appetite to do more in China,” Noordaa emphasized.

ING now has two insurance joint ventures in China – ING Capital Life and ING Pacific Life. ING holds 50 percent each in the two joint ventures and is ranked the No. 8 foreign insurer in China’s insurance market among overseas players.

Noordaa said ING has no plan to merge its two existing insurer joint ventures.

The Dutch financial player also owns 16.1 percent of Bank of Beijing.

Methane JVs lure foreigners

CHINA has issued new rules to allow more companies to cooperate with foreign partners to explore for methane trapped in coal seams to boost energy output.

Companies designated by the State Council, China’s Cabinet, will be allowed to set up the ventures with foreign businesses, according to a revised regulation posted on the Chinese government’s Website yesterday. China United Coalbed Methane Corp used to be the only company allowed to enter such ventures based on a 2001 regulation.

The central government aims to boost the share of its energy produced from natural gas to 5.3 percent by 2010 from about three percent now to cut pollution and reduce reliance on coal and oil, Bloomberg News reported. China has 10 trillion cubic meters of extractable coal-bed methane reserves, according to the National Development and Reform Commission, the nation’s top economic planner.

Asia American Gas Inc and China United Coalbed Methane won government approval to produce 500 million cubic meters of the fuel annually in northern China’s Shanxi Province.

Intel Begins Work on $2.5 Billion Chip Plant in China

Sept. 8 (Bloomberg) — Intel Corp., the world’s largest semiconductor maker, began building its first computer-chip manufacturing plant in China, a $2.5 billion investment.

Intel Chairman Craig Barrett is hosting a ceremony today in Dalian, in northeastern China, on the site of what will become the company’s first chip factory in Asia. Intel already has plants for testing and assembling products in other parts of China, the world’s biggest market for chips.

Intel, which announced the project in March, aims to begin production at the plant by 2010. The factory will bring the Santa Clara, California-based company’s total investment in China to almost $4 billion, Barrett said. The plant will give Intel better access to computer factories in China, as the company seeks to regain sales lost to Advanced Micro Devices Inc.

Intel plans to employ 1,200 people at the Dalian plant in China, its first factory in a new location in 15 years. It will begin hiring this year, with most of the recruitment taking place in the second half of 2008 through China’s universities, said Vice President Kirby Jefferson, who heads the plant that is also known as Fab 68.

The plant will “be an integral part of our global manufacturing network, while bringing us closer to our customers and partners in China,” Barrett said.

The Dalian plant will make chipsets, the supporting semiconductors that link Intel’s main product, microprocessors, to the rest of the computer.

Intel also plans to donate 8-inch chip-manufacturing equipment to the Dalian municipal government and the Dalian University of Technology to help establish a 348 million yuan ($46 million) semiconductor technology institute, Barrett said.

It joins STMicroelectronics NV, Taiwan Semiconductor Manufacturing Co. and South Korea’s Hynix Semiconductor Inc. in building factories in China.

Investing China: Risks, opportunities, incentives

What are the risks attached to investing from abroad into China? What are the best ways to minimise these risks?

Risks are high in doing business in China because anything can happen, including political revolution, financial crisis, labour uproar, etc. However, the general return is high too – China is one of the fastest-growing markets with an annual growth rate approaching 10% in the past 10 consecutive quarters.

The key to success in China is to fully realise the risks and have a flexible action plan to minimise them. The following are, in my opinion, the most critical risks that may have a direct impact on foreign investment in China.

Undeveloped credit infrastructure

A common complaint of foreign companies doing business in China, or with Chinese companies, is about the difficulty of collecting full payment on time. China does not have a credit infrastructure that provides systematic and reliable resources to the credit history of companies and individuals.

Foreign companies should do good due diligence to minimise exposure to the risk of default on payment. It is worth investing time and money on extensive research and retaining a reliable third-party expert to find reputable partners and confirm the creditworthiness of partners or primary customers.

In addition, companies should pay close attention to the terms of payments and performance standards in contracts and verify the authority of Chinese people involved in negotiating and concluding these contracts. Make sure that contracts do not include provisions that violate Chinese law, even though the Chinese parties may promise not to enforce laws or regulations, and do not accept provisions that are beyond your control, such as visas for visits to your company in Europe or the US.

Poor legal environment

The existing Chinese legal system does not provide adequate and effective protection. The application of laws is inconsistent in different provinces and cities, and court verdicts are difficult to enforce. Cost of litigation is high, and penalties are low. Contracts are not fully respected and difficult to enforce. Bear in mind that the conclusion of a contract is just the beginning of real negotiation.

Verify the authority of the people you negotiate with and the ownership, permits, permissions, license and qualifications they claim that they have through independent sources. Find your own legal counsel and draft contracts in clear terms.

Do not rely on oral promises of business partners and government officials on local subsidies, incentives or special considerations that are not based on solid legal ground. Even if you have them in writing, you should treat these incentives as ways to augment profit (instead of counting on them to create profit) because they may be taken away at any time.

Lack of electric power supply

In recent years, more than two-thirds of China’s provinces and municipalities have experienced chronic power shortages, with the most serious in the high-density industrial areas along the east coast.

In response, the Chinese government has approved several dozen new power plant projects, which are expected to add fresh capacity of about 35 million kilowatts, to come online in 2006 and 2007. However, there are concerns about the viability and sufficiency of such projects, because most of the approved new facilities are located in central China and it is in doubt whether the poor regional grid infrastructure can adequately transfer the added power to high-demand areas long the east coast.

Furthermore, it is expected that China’s energy sector will have to be reformed from a controlled to a market pricing system, which calls for price deregulation. This means that prices of electric power may eventually be adjusted to meet the market demand.

Many foreign companies have started to shift manufacturing investment to smaller cities in central and west China, where power capacity for industrial use is more stable and adequate, and labour and land cost are lower than in large cities along the east coast. In addition, many companies have purchased diesel generators as a back-up to maintain production during peak power times.

As a result, foreign companies may want to include the expense of diesel generators as a fixed cost of investing in China and raise their estimate of costs to account for power supply uncertainties in east and south China.

Diverse and rapidly changing market

China is a very diverse market. With 1.3 billion in population, the consumer culture, cuisine and local languages are dramatically different in provinces from north to south and from east to west. The overall market has been growing rapidly but regional economy has developed at very different paces.

In addition, China has a long history of strong regional protectionism where provincial and municipal governments impose barriers to the inward trade of goods and services from other regions to protect local businesses and tax revenue. It is challenging for foreign companies to penetrate regional markets because products that are well received in one city are not necessarily welcome in other areas in China.

Foreign companies need to be very sensitive to, and make marketing strategies taking into consideration, the regional differences and barriers. It is a mistake to assume that products popular in large cities or the east coast region will eventually find their ways into second-tier cities and the mid-west region.

Before jumping into these markets or launching a new product, it is critical that foreign companies do substantial and in-depth market research and keep close track of regional developments.

Difference in culture and management styles

The cultural differences between China and the West are striking. For example, in China telling a guest that he or she has gained weight recently is a compliment, and the honoured guests at a dinner party can expect to be given the head and tail of the fish to eat. To share and ask about personal matters is an expression by management of caring and respect for employees in Chinese companies, where the same questions may be seen as an invasion of privacy in the West.

Foreign companies doing business in China need to become familiar with basic Chinese culture and critical differences in business etiquette. Hiring managers who grew up in China and were trained overseas may help to smooth the potential conflicts in cultural and management styles.

What particular guidance can be given to smaller-sized to mid-market businesses looking to invest in China?

Find the right partner and make investments step by step
Small firms usually need a local Chinese business partner to make sales, deliver products and develop local markets. Companies may start by working with potential partners on low-cost products or under the consignment manufacturing arrangement to test their quality, capacity, efficiency and reliability before making substantial investment on forming joint ventures with a local partner or investing in factories and other capital expenditures.

Another approach is to set up liaison offices and hire a few Chinese employees to obtain first-hand market information and build customer relationships. Alternatively, foreign companies may form joint ventures with Chinese partners with small amounts of investment and gradually increase the investment and eventually buy out these Chinese partners after they obtain a more solid market foothold.

Hire good local managers and advisors

Smaller firms tend to be cost sensitive. However, firms that are willing to pay for the best managers and advisors usually get significant return in the long run.

Advisors who have substantial experience in advising foreign companies doing business in China and in-depth familiarity with Western management and business models may help foreign companies identify the most cost-efficient market entry strategy and sustainable operating model for their Chinese investment. Smaller firms should invest in hiring and training the best local managers, instead of sending expatriates to work in China. Usually, periodic overseas training opportunities are very attractive to offer and an effective way of retaining and rewarding the best Chinese employees.

Be realistic and patient

Do not rely on the promises of subsidies and incentives of local government officials and partners to project your profitability. Use independent sources to verify your partners’ claims of ownership, permits, permissions, licenses, and professional qualifications. Do a thorough risk analysis and have solutions for the worst situations in every phase of developments. Do not compromise on risk assessment standards just because the trend is to go to China. Be patient in waiting for acceptable terms and return on investment.

In which business sectors are there the most/least risks, and why? In which sectors are the Chinese most /least receptive to investment?

It is difficult to a draw a general line between the highest and lowest risk industries in China because foreign investments are prohibited or restricted in some industries.

The State Council issued the Guidelines for Industries with Foreign Investment as a primary basis for foreign companies to find out whether foreign investment in a particular industry is encouraged, permitted, restricted or prohibited. The next step is to check the local government’s industry policy in a particular province or city where you plan to make the investment.

In general, consumer and consumption-related companies benefit the most from China’s 1.3 billion population and fast growth. We have seen companies that reported double or triple digit growth in annual revenue in their operations that manufacture and sell furniture, construction and interior decoration materials, cleaning and sanitising products, and auto parts in China.

What incentives are offered?

China offers tremendous incentives. The basic tax incentive is the so-called ‘five-year tax holiday’, including a two-year income tax exemption followed by a three-year 50% income tax rate reduction starting from the first profit-making year to manufacturing-oriented foreign investment enterprises with a minimum 10-year business operation.

In addition, the regular corporate income tax rate is reduced from 33% to 24%, 15% or even 10% in various economic, technology or special development zones. There are incentives offered based on industries and transactions, incentives on business tax, value added tax, customs duty and other transactions tax. Local governments usually offer fiscal subsidies and tax refunds. The key is to identify what is on the table and verify incentives with independent advisors.

Emerson hot on Nanjing

US-BASED Emerson Process Management Co Ltd plans to invest US$30 million to build a production facility in Nanjing.

The Asia Flow Technologies Center will be the company’s sole production base in Asia and the fourth of its kind worldwide. The others are in the United States, Canada and Mexico.

China has become Emerson’s second-largest market after the US, and building a plant here is part of the company’s strategy to capitalize on the growing market in the Asia-Pacific region, said Mike Train, president of Emerson Process Management Asia-Pacific.

The facility, to be located in the Nanjing Jiangning Science Park, will cover about 12,500 square meters. It is expected to be completed in 2008.

The plant will produce process control equipment, including flow meters, density meters and ultrasonic devices, officials said.

Emerson first licensed technology to China in 1979 and opened its first factory in the country in 1992.

China: Big Pharma’s new New Jersey

The big drugmakers are pouring money into the People’s Republic, but product recalls cast a shadow.

NEW YORK (CNNMoney.com) — U.S. drugmakers are investing heavily in China, but experts say the People’s Republic needs to cast off its image as a maker of toxic recalls before it can rival New Jersey – home of half of the world’s top 10 pharmaceutical companies – as a big hub for Big Pharma.

China’s strong domestic market for pharmaceuticals has fueled interest from Western investors, who find the allure of cheap labor irresistible. The Chinese drug market is red hot, with sales jumping 12.3 percent in 2006 to $13.4 billion, according to IMS Health. Sales are projected to more than double by 2010.

Western drugmakers and biotechs – Merck (Charts, Fortune 500), Wyeth (Charts, Fortune 500), Eli Lilly & Co., (Charts, Fortune 500) Schering-Plough (Charts, Fortune 500), Novartis (Charts), Sanofi-Aventis, Biomed and Genentech, to name a few – are ramping up investments in China, as well as in India and Singapore, according to a report from PricewaterhouseCoopers analyst Dan Bartholomew.

In addition, China, India and Singapore have their own home-grown industries, while South Korea, Thailand and the Philippines are rapidly increasing healthcare spending.

“The tide towards production in pan-Asia is something that’s not going to stop,” said Bartholomew. “It’s just a question of the measures that are put in place to do it the right way.”

Mattel recalls over 9M toys
But all is not well in the People’s Republic. In recent months, “Made in China” has become synonymous with faulty products, including counterfeit toothpaste containing dangerous levels of a chemical found in antifreeze, car tires with a tendency to disintegrate, and toys coated with dangerous lead paint.

U.S. companies have announced the recall of millions of Chinese-made toys, the most recent being Tuesday’s announcement of more than 9 million Mattel Inc. (Charts, Fortune 500) toys.

Also this summer, the “Made in China” stamp has been marred by two high-profile deaths: the suicide of Zhang Shuhong of Hong Kong, contract manufacturer for Mattel, and the execution of Zheng Xiaoyu, former chief of China’s State Food and Drug Administration, for accepting bribes to approve drugs.

China’s State Food and Drug Administration has vowed to invest more than $1 billion through 2010 to strengthen its food and drug safety program. But there’s a question concerning whether this is enough.

“The Chinese FDA just doesn’t have the infrastructure,” said Les Funtleyder, drug analyst for Miller Tabak. “They don’t have the hundreds of inspectors who go out [to check factories.] They don’t have the training. Until they bring things up to speed, I’m not sure the [U.S.] FDA is going to just accept drugs made in China.”

That hasn’t stopped Pfizer, Baxter, Bayer and Roche from investing in Chinese manufacturing. Big Pharma is lured by a strong local market and the possibility of cheap manufacturing for eventual export.

FDA accuses Pfizer of false advertising
Dan Bartholomew of PricewaterhouseCoopers added that much of the recent outside interest in China, such as $100 million investments from Novartis and AstraZeneca, is for research and development because clinical trials are comparatively cheap to run in Asia.

This is despite the region’s laissez-faire attitude to patents and intellectual property. Even in China, where “IP” (as the Americans call it) has long been considered a foreign concept, strides have been made to protect the patent-holders.

In 2006, a Beijing court ruled in favor of Pfizer in a patent dispute over Viagra, and this sent a strong positive message to U.S. drugmakers, said Bartholomew. The analyst claimed that R&D investments from Novartis, AstraZeneca and other Western drugmakers are a “huge statement” that their property will be protected.

The investments could be stepping stones to manufacturing, said Bartholomew, who projects that Chinese factories could be making drugs for the U.S. market within five years.

But analysts said this would only happen if aggressive measures are taken – by outside investors – to ensure sound product quality, and also to cut down on counterfeiting. Otherwise, legitimate manufacturers could have their brand-names misappropriated for use on dangerous and illegal copies, as occurred in the recent abuse of the Colgate brand by toothpaste counterfeiters.

But China-U.S.business relations can be notoriously complex, and quality control to meet the standards of U.S. regulators could take a bite out of the benefits of cheap labor.

“The bureaucracy in China is going to be less flexible and more serpentine [than U.S. regulators] and will take longer to get change and cooperation for change to really occur,” said Robert Toomey, drug analyst for E.K. Riley Investments. “I think it comes down to economics. Is the need for cheaper labor offset by the need for more oversight of the process?”

The specter of a Vioxx-style recall hangs heavily over the prospect of Chinese-made exports to the U.S., analysts said, and it could spell big trouble for the industry.

“All it will take is one contaminated batch of drugs from China and your pharma company will have really big problems,” said Funtleyder of Miller Tabak. “Given the skepticism around China, I’m not sure that a production facility in the continent to ship back here is worth doing.”

All Eyes Are On Outsourcing Providers In China

Francisco Partners’ investment in DarwinSuzsoft and Sierra Atlantic’s acquisition of ArrAy highlight increasing focus on Chinese outsourcing capabilities.

Mark Botticelli has learned valuable lessons about China. For one, employees expect cash bonuses before important holidays, like the Chinese New Year. And horizontal organizations don’t work.

“Hierarchy is important,” says Botticelli, VP of engineering in the mobile solutions division at Trimble, which makes software for devices used by delivery people and other mobile workers. “The project manager needs to go home and tell his wife he has 14 people working for him.”

Trimble eased its way through these cultural challenges three years ago by hiring Chinese outsourcer Suzsoft to provide engineering services. This is a path more U.S. companies are likely to follow, making companies like Suzsoft–now DarwinSuzsoft since being acquired by Darwin Partners last year–increasingly popular.

As a measure of that popularity, private equity firm Francisco Partners last week said it would invest $48 million and take a majority stake in DarwinSuzsoft. The investment will be used for acquisitions and organic growth of the U.S. company, which employees 800 Chinese engineers. Also last week, Sierra Atlantic, a U.S. IT services firm with 1,100 developers in Hyderabad, India, said it’s acquiring ArrAy, a U.S. company with 200 engineers in Guangzhou and Shanghai.

It’s not just the small services providers gearing up: IBM, Tata Consultancy Services, and others have plans to hire thousands more engineers in China. Oracle late last month set up a second Chinese development center to support software partners and integrators, and introduced a computer science program for vocational schools in a deal with the Chinese government.

Companies doing offshore development in China say they’re paying salaries that are 25% to 40% lower than what they’d pay in India, without the high staff turnover rates in that country. Chet Gapinski,VP of engineering at Crossbeam Systems, a maker of security systems, steered his company to China last year after facing some of those problems in India. Crossbeam hired ArrAy for a “hybrid” approach that keeps project managers in the United States and engineers in China, with both sides making regular visits to the other country.

Crossbeam initially had difficulty getting U.S. visitors’ visas for Chinese engineers, a problem ArrAy smoothed over, Gapinski says. It also found that Chinese engineers can’t work on some security technologies deemed sensitive by the U.S. government. In China, experienced service providers also can prevent problems dealing with government, which is closely involved in business.

Trimble, which employs 30 of DarwinSuzsoft’s Chinese engineers, has expanded its relationship beyond developing custom apps for a Hong Kong customer to include maintenance for U.S. and Chinese customers and development work on Trimble products.

Botticelli initially was concerned about lax intellectual property protection in China but found Suzsoft’s security measures more than adequate. English skills aren’t nearly as good as in India, so Trimble requires its Chinese engineers to attend weekly English classes. One sign of success in China: Trimble plans to ramp up its team there to handle new products coming out next year.

51job, Inc: Marketing Expenses and High Taxation Dent EPS Estimates

Ashish R. Thadhani (Gilford Securities) recently sent a note to clients on Chinese human resource recruitment company 51job, Inc. (JOBS). Excerpts follow:

• Investment Conclusion. Based on stepped-up S&M spending and the expiration of key tax benefits – tempered by print advertising and training/outsourcing revenue — we are reducing our estimates: 2007 GAAP EPADS to $0.50 on net revenue of $103 million (23% YoY growth) from $0.60 on net revenue of $100 million; and 2008 GAAP EPADS to $0.68 on net revenue of $125 million (22% YoY growth) from $0.80 on net revenue of $121 million. We are introducing a 2009 GAAP EPADS estimate of $0.90 on net revenue of $152 million (21% YoY growth). We are also lowering our target from $28 to $21.50. In 12-months, this would correspond to a $465 million enterprise value and 25-30x forward GAAP EPADS – in line with 26% compound EPS growth in 2006-09E and a discount to the current valuation (32x). We are disheartened by the aggressive emphasis on marketing initiatives at the expense of long overdue margin/EPS discipline. This represents the third investor setback in as many years, undermines claims of market domination and also raises questions about management alignment (see April 2006 agreement on page 2). Still, we believe that 25% upside potential justifies a Buy.

• 2Q07 Results. GAAP EPADS of $0.14 vs. $0.12 a year ago on net revenue of $26.2 million (28% YoY growth) fell short of our $0.16 estimate on net revenue of $25.1 million. EPADS was held back by $0.02 due to a high tax-rate. 51job posted a positive variance in revenue ($1.1 million primarily in print advertising and training/outsourcing) – offset by operating costs ($0.6 million), forex ($0.2 million) and taxes ($0.7 million). Revenue from online recruitment services advanced 36% YoY to 34% of the total. Operating income rose 54% YoY to $5.7 million (21.6% margin) and surpassed our $5.2 million estimate (20.8% margin). Results benefited from a longer post- Chinese New Year peak recruiting period in 2Q07 vs. a year ago. Metrics showed improving growth in print advertising page-count (+37% YoY) but lower average revenue per page (-15% YoY in dollar terms attributed to city-mix); and normal growth in the number of employers using online services (+32% YoY) with steady revenue per employer (+3% YoY). Net cash climbed to $126.0 million (or $4.45 per ADS) from $119.0 million on March 31.

• Investment Thesis. 51job is enviably placed to capitalize on the rapidly evolving market for HR services in China – by applying a proven business model across its vast labor force (5x U.S.). Compared with traditional job search channels such as referrals and fairs, pioneers like 51job offer significant reach and speed advantages. Favorable demographic drivers include GDP growth (~10% in recent years), Internet usage (ranked #2 behind the U.S.), an aging workforce and increasing private, urban and service sector employment. iResearch forecasts that the total recruitment market in China will increase from $568 million to $1.33 billion in 2005-10, implying 19% compound annual growth. During this period, the online recruitment segment is expected to advance from $99 million (17% of the total) to $604 million (45%), or 44% compound annual growth. Superior positioning includes: premium brand/pricing; a comprehensive online/offline offering; wide geographic presence (25 cities); large direct sales force (over 1,500 representatives); and unmatched job seeker database (access to more than 12 million resumes for professional, clerical, industrial and hourly jobs). EPS visibility stands to benefit from top-line and profitability drivers. Specifically, ramp-up of online subscriptions (from single-digit penetration of client budgets at present) and a scalable model offering 30%-plus operating margin (excluding share-based compensation).

• JOBS is suitable for aggressive investors. In our opinion, principal risks include the following:

– Deterioration of economic conditions in China, slowing of hiring activity or a “hard landing” scenario.
– Competition from ChinaHR.com and Internet portals could pressure future profitability by way of lower pricing and/or higher marketing expenses.
– Rapid online migration could result in cannibalization of offline revenue.
– 51job has an inconsistent execution record.
– Uncertainties in the PRC regulatory and legal system, particularly laws governing foreign ownership and licensing/operation of HR and Internet business entities. Note that 51job is incorporated as a holding company in the Cayman Islands.
– Disruptions such as spread of the H5N1 virus or a recurrence of SARS, political unrest, breakdown in relationship with a major publishing/distribution contractor, etc.
– Influence of Recruit Co. and current management over all matters requiring a shareholder vote.
– Correction in the U.S. markets.